Logo image of MIR

MIRION TECHNOLOGIES INC (MIR) Stock Fundamental Analysis

NYSE:MIR - New York Stock Exchange, Inc. - US60471A1016 - Common Stock - Currency: USD

13.8  -0.04 (-0.29%)

After market: 13.8 0 (0%)

Fundamental Rating

3

Overall MIR gets a fundamental rating of 3 out of 10. We evaluated MIR against 124 industry peers in the Electronic Equipment, Instruments & Components industry. MIR may be in some trouble as it scores bad on both profitability and health. MIR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MIR had positive earnings in the past year.
In the past year MIR had a positive cash flow from operations.
In the past 5 years MIR always reported negative net income.
MIR had a positive operating cash flow in each of the past 5 years.
MIR Yearly Net Income VS EBIT VS OCF VS FCFMIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

MIR has a Return On Assets (-1.37%) which is comparable to the rest of the industry.
The Return On Equity of MIR (-2.40%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 0.88%, MIR perfoms like the industry average, outperforming 50.81% of the companies in the same industry.
Industry RankSector Rank
ROA -1.37%
ROE -2.4%
ROIC 0.88%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR Yearly ROA, ROE, ROICMIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

With a Operating Margin value of 3.08%, MIR perfoms like the industry average, outperforming 56.45% of the companies in the same industry.
MIR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 46.43%, MIR is in the better half of the industry, outperforming 79.84% of the companies in the same industry.
In the last couple of years the Gross Margin of MIR has grown nicely.
Industry RankSector Rank
OM 3.08%
PM (TTM) N/A
GM 46.43%
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
MIR Yearly Profit, Operating, Gross MarginsMIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MIR is destroying value.
Compared to 1 year ago, MIR has more shares outstanding
MIR has a worse debt/assets ratio than last year.
MIR Yearly Shares OutstandingMIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
MIR Yearly Total Debt VS Total AssetsMIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

MIR has an Altman-Z score of 1.92. This is not the best score and indicates that MIR is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.92, MIR is doing worse than 66.94% of the companies in the same industry.
MIR has a debt to FCF ratio of 13.65. This is a negative value and a sign of low solvency as MIR would need 13.65 years to pay back of all of its debts.
MIR's Debt to FCF ratio of 13.65 is in line compared to the rest of the industry. MIR outperforms 52.42% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that MIR is not too dependend on debt financing.
MIR's Debt to Equity ratio of 0.46 is on the low side compared to the rest of the industry. MIR is outperformed by 67.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 13.65
Altman-Z 1.92
ROIC/WACC0.1
WACC8.99%
MIR Yearly LT Debt VS Equity VS FCFMIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.26 indicates that MIR has no problem at all paying its short term obligations.
MIR has a Current ratio of 2.26. This is comparable to the rest of the industry: MIR outperforms 48.39% of its industry peers.
A Quick Ratio of 1.75 indicates that MIR should not have too much problems paying its short term obligations.
MIR has a Quick ratio (1.75) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 1.75
MIR Yearly Current Assets VS Current LiabilitesMIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

MIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.59%, which is quite impressive.
Looking at the last year, MIR shows a small growth in Revenue. The Revenue has grown by 7.48% in the last year.
The Revenue has been growing by 14.36% on average over the past years. This is quite good.
EPS 1Y (TTM)20.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.33%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%10.37%

3.2 Future

Based on estimates for the next years, MIR will show a very strong growth in Earnings Per Share. The EPS will grow by 21.02% on average per year.
The Revenue is expected to grow by 6.95% on average over the next years.
EPS Next Y14.75%
EPS Next 2Y18.05%
EPS Next 3Y21.02%
EPS Next 5YN/A
Revenue Next Year5.77%
Revenue Next 2Y6.6%
Revenue Next 3Y6.95%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MIR Yearly Revenue VS EstimatesMIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MIR Yearly EPS VS EstimatesMIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

MIR is valuated quite expensively with a Price/Earnings ratio of 33.66.
Compared to the rest of the industry, the Price/Earnings ratio of MIR is on the same level as its industry peers.
MIR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 29.33, the valuation of MIR can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as MIR.
The average S&P500 Price/Forward Earnings ratio is at 21.08. MIR is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 33.66
Fwd PE 29.33
MIR Price Earnings VS Forward Price EarningsMIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

MIR's Enterprise Value to EBITDA ratio is in line with the industry average.
MIR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 63.53
EV/EBITDA 20.89
MIR Per share dataMIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MIR does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as MIR's earnings are expected to grow with 21.02% in the coming years.
PEG (NY)2.28
PEG (5Y)N/A
EPS Next 2Y18.05%
EPS Next 3Y21.02%

0

5. Dividend

5.1 Amount

No dividends for MIR!.
Industry RankSector Rank
Dividend Yield N/A

MIRION TECHNOLOGIES INC

NYSE:MIR (4/17/2025, 8:04:01 PM)

After market: 13.8 0 (0%)

13.8

-0.04 (-0.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)04-30 2025-04-30
Inst Owners83.11%
Inst Owner Change0%
Ins Owners2.29%
Ins Owner Change17.57%
Market Cap3.20B
Analysts84.44
Price Target20.4 (47.83%)
Short Float %2.1%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.95%
Min EPS beat(2)-11.99%
Max EPS beat(2)13.88%
EPS beat(4)2
Avg EPS beat(4)7.43%
Min EPS beat(4)-11.99%
Max EPS beat(4)32.01%
EPS beat(8)6
Avg EPS beat(8)11.89%
EPS beat(12)8
Avg EPS beat(12)5.05%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.53%
Max Revenue beat(2)2.76%
Revenue beat(4)2
Avg Revenue beat(4)0.06%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)2.76%
Revenue beat(8)6
Avg Revenue beat(8)1.7%
Revenue beat(12)7
Avg Revenue beat(12)0.99%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.49%
EPS NY rev (1m)-2.67%
EPS NY rev (3m)-8.04%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)-2.97%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 33.66
Fwd PE 29.33
P/S 3.71
P/FCF 63.53
P/OCF 32.25
P/B 2.12
P/tB N/A
EV/EBITDA 20.89
EPS(TTM)0.41
EY2.97%
EPS(NY)0.47
Fwd EY3.41%
FCF(TTM)0.22
FCFY1.57%
OCF(TTM)0.43
OCFY3.1%
SpS3.72
BVpS6.5
TBVpS-1.43
PEG (NY)2.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.37%
ROE -2.4%
ROCE 1.12%
ROIC 0.88%
ROICexc 0.96%
ROICexgc 5.92%
OM 3.08%
PM (TTM) N/A
GM 46.43%
FCFM 5.84%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y18.71%
ROICexcg growth 5YN/A
ROICexc growth 3Y10.74%
ROICexc growth 5YN/A
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 13.65
Debt/EBITDA 3.87
Cap/Depr 32.45%
Cap/Sales 5.67%
Interest Coverage 0.48
Cash Conversion 56.02%
Profit Quality N/A
Current Ratio 2.26
Quick Ratio 1.75
Altman-Z 1.92
F-Score6
WACC8.99%
ROIC/WACC0.1
Cap/Depr(3y)24.94%
Cap/Depr(5y)26.34%
Cap/Sales(3y)5.02%
Cap/Sales(5y)4.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.33%
EPS Next Y14.75%
EPS Next 2Y18.05%
EPS Next 3Y21.02%
EPS Next 5YN/A
Revenue 1Y (TTM)7.48%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%10.37%
Revenue Next Year5.77%
Revenue Next 2Y6.6%
Revenue Next 3Y6.95%
Revenue Next 5YN/A
EBIT growth 1Y290.65%
EBIT growth 3Y33.25%
EBIT growth 5Y-1.65%
EBIT Next Year380.38%
EBIT Next 3Y85.44%
EBIT Next 5YN/A
FCF growth 1Y-13.43%
FCF growth 3Y18.28%
FCF growth 5YN/A
OCF growth 1Y4.1%
OCF growth 3Y22.74%
OCF growth 5Y46.47%